| Schedule of Segment Information |
Selected financial information for the Company’s
operating segments was as follows:
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
2,069,019 |
|
|
$ |
4,055,774 |
|
|
$ |
3,909,110 |
|
|
$ |
9,161,039 |
|
| Clinical Laboratory Operations |
|
|
- |
|
|
|
5,415 |
|
|
|
1,440 |
|
|
|
90,800 |
|
| |
|
$ |
2,069,019 |
|
|
$ |
4,061,189 |
|
|
$ |
3,910,550 |
|
|
$ |
9,251,839 |
|
| Net income (loss) from continuing operations before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
(2,323,338 |
) |
|
$ |
(4,002,213 |
) |
|
$ |
(5,416,271 |
) |
|
$ |
(7,177,320 |
) |
| Clinical Laboratory Operations |
|
|
(293,456 |
) |
|
|
(180,028 |
) |
|
|
(406,842 |
) |
|
|
(405,558 |
) |
| Corporate |
|
|
(696,510 |
) |
|
|
(914,074 |
) |
|
|
(1,342,376 |
) |
|
|
(1,986,909 |
) |
| Other income (expense), net |
|
|
5,418,759 |
|
|
|
(8,183,261 |
) |
|
|
2,400,456 |
|
|
|
(16,642,584 |
) |
| Benefit from income taxes |
|
|
- |
|
|
|
- |
|
|
|
1,118,485 |
|
|
|
- |
|
| |
|
$ |
2,105,455 |
|
|
$ |
(13,279,576 |
) |
|
$ |
(3,646,548 |
) |
|
$ |
(26,212,371 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
176,998 |
|
|
$ |
176,371 |
|
|
$ |
359,313 |
|
|
$ |
350,147 |
|
| Clinical Laboratory Operations |
|
|
4,041 |
|
|
|
9,683 |
|
|
|
(13,702 |
) |
|
|
59,345 |
|
| Corporate |
|
|
52 |
|
|
|
182 |
|
|
|
187 |
|
|
|
330 |
|
| |
|
$ |
181,091 |
|
|
$ |
186,236 |
|
|
$ |
345,798 |
|
|
$ |
409,822 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
10,435 |
|
|
$ |
1,398 |
|
|
$ |
10,435 |
|
|
$ |
43,715 |
|
| |
|
$ |
10,435 |
|
|
$ |
1,398 |
|
|
$ |
10,435 |
|
|
$ |
43,715 |
|
| |
|
As of |
|
| |
|
June 30, 2020 |
|
|
December 31, 2019 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
12,813,219 |
|
|
$ |
14,275,256 |
|
| Clinical Laboratory Operations |
|
|
450,212 |
|
|
|
330,381 |
|
| Corporate |
|
|
4,457,937 |
|
|
|
2,305,380 |
|
| Assets of AMSG and HTS classified as held for sale |
|
|
212,018 |
|
|
|
514,772 |
|
| Eliminations |
|
|
(2,718,130 |
) |
|
|
(2,718,130 |
) |
| |
|
$ |
15,215,256 |
|
|
$ |
14,707,659 |
|
|